Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06352866
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-04-02
Brief Title:
Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w Teclistamab in RRMM
Sponsor:
Jack Khouri
Organization:
Case Comprehensive Cancer Center
Organization Data
Organization:
Case Comprehensive Cancer Center
Class:
OTHER
Study ID:
CASE3A23
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jack Khouri
Lead Sponsor Class:
OTHER
Responsible Party:
Jack Khouri
Responsible Party Title:
Principal Investigator MD
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Case Comprehensive Cancer Center
Old Name:
None
Old Organization:
None